BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 16224252)

  • 1. New developments in scleroderma interstitial lung disease.
    Highland KB; Silver RM
    Curr Opin Rheumatol; 2005 Nov; 17(6):737-45. PubMed ID: 16224252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interstitial lung disease in scleroderma.
    Schoenfeld SR; Castelino FV
    Rheum Dis Clin North Am; 2015 May; 41(2):237-48. PubMed ID: 25836640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interstitial lung disease in systemic sclerosis.
    Ostojic P; Cerinic MM; Silver R; Highland K; Damjanov N
    Lung; 2007; 185(4):211-20. PubMed ID: 17717851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in the diagnosis and treatment of interstitial lung disease in systemic sclerosis (scleroderma): a review.
    Tan A; Denton CP; Mikhailidis DP; Seifalian AM
    Clin Exp Rheumatol; 2011; 29(2 Suppl 65):S66-74. PubMed ID: 21586221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interstitial lung disease in systemic sclerosis.
    Cheema GS; Quismorio FP
    Curr Opin Pulm Med; 2001 Sep; 7(5):283-90. PubMed ID: 11584177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent progress in systemic sclerosis-interstitial lung disease.
    Castelino FV; Dellaripa PF
    Curr Opin Rheumatol; 2018 Nov; 30(6):570-575. PubMed ID: 30234724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation and management of alveolitis and interstitial lung disease in scleroderma.
    Latsi PI; Wells AU
    Curr Opin Rheumatol; 2003 Nov; 15(6):748-55. PubMed ID: 14569205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers from bronchoalveolar lavage fluid in systemic sclerosis patients with interstitial lung disease relate to severity of lung fibrosis.
    Hesselstrand R; Wildt M; Bozovic G; Andersson-Sjöland A; Andréasson K; Scheja A; Westergren-Thorsson G; Bjermer L; Wuttge DM
    Respir Med; 2013 Jul; 107(7):1079-86. PubMed ID: 23660398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation and management approaches for scleroderma lung disease.
    Schoenfeld SR; Castelino FV
    Ther Adv Respir Dis; 2017 Aug; 11(8):327-340. PubMed ID: 28621173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bronchoalveolar lavage fluid in scleroderma interstitial lung disease: technical aspects and clinical correlations: review of the literature.
    Kowal-Bielecka O; Kowal K; Highland KB; Silver RM
    Semin Arthritis Rheum; 2010 Aug; 40(1):73-88. PubMed ID: 19152959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease.
    Benyamine A; Heim X; Resseguier N; Bertin D; Gomez C; Ebbo M; Harlé JR; Kaplanski G; Rossi P; Bardin N; Granel B
    Rheumatol Int; 2018 May; 38(5):813-819. PubMed ID: 29455320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bronchoalveolar Lavage in Systemic Sclerosis Patients: A Systematic Review.
    da Silva SO; da Paz AS; Farias IMVC; Moreira DS; Ribeiro MAF; Alves TSGN; Lemos ACM; Santiago MB
    Curr Rheumatol Rev; 2021; 17(2):176-183. PubMed ID: 33185168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interstitial lung disease in systemic sclerosis.
    Wells AU; Margaritopoulos GA; Antoniou KM; Denton C
    Semin Respir Crit Care Med; 2014 Apr; 35(2):213-21. PubMed ID: 24668536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eosinophilic globules in bronchoalveolar lavage fluid of patients with systemic sclerosis-related interstitial lung disease: a diagnostically useful, previously unreported finding in a retrospective and prospective study, including differential diagnosis with other idiopathic and secondary interstitial lung diseases.
    Rossi G; Andreani A; Morandi P; Marchioni A; Corradini P; Cappiello G; Bortolotti M; Qosja A; Manzini C; Ferri C; Richeldi L; Cavazza A
    Am J Clin Pathol; 2008 Dec; 130(6):927-33. PubMed ID: 19019770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary involvement in systemic sclerosis.
    Morales-Cárdenas A; Pérez-Madrid C; Arias L; Ojeda P; Mahecha MP; Rojas-Villarraga A; Carrillo-Bayona JA; Anaya JM
    Autoimmun Rev; 2016 Nov; 15(11):1094-1108. PubMed ID: 27497912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interstitial lung disease and myositis in a patient with simultaneously occurring sarcoidosis and scleroderma.
    Groen H; Postma DS; Kallenberg CG
    Chest; 1993 Oct; 104(4):1298-300. PubMed ID: 8404219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interstitial lung disease in systemic sclerosis: progress in screening and early diagnosis.
    Molberg Ø; Hoffmann-Vold AM
    Curr Opin Rheumatol; 2016 Nov; 28(6):613-8. PubMed ID: 27387267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lung interstitial disease in systemic sclerosis: semiologic characteristics with high-resolution computerized tomography and comparison with other methods].
    Rotondo A; Grassi R; Catalano O; Del Viscovo L; Vatti M; Gallo M; Bianco L; Celentano L; Brunetti A; Rivellini M
    Radiol Med; 1993 Sep; 86(3):213-9. PubMed ID: 8210528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of pulmonary function tests and biomarkers studies to diagnose and follow-up interstitial lung disease in systemic sclerosis].
    Hua-Huy T; Rivière S; Tiev KP; Dinh-Xuan AT
    Rev Pneumol Clin; 2014 Dec; 70(6):335-42. PubMed ID: 25457218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desquamative interstitial pneumonia as the initial manifestation of systemic sclerosis.
    Swartz JS; Chatterjee S; Parambil JG
    J Clin Rheumatol; 2010 Sep; 16(6):284-6. PubMed ID: 20808169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.